BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Odagiri N, Matsubara T, Sato-Matsubara M, Fujii H, Enomoto M, Kawada N. Anti-fibrotic treatments for chronic liver diseases: The present and the future. Clin Mol Hepatol 2021;27:413-24. [PMID: 33317250 DOI: 10.3350/cmh.2020.0187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Sung P, Kim C, Cha J, Park J, Yu Y, Wang H, Kim J, Bae S. A Unique Immune-Related Gene Signature Represents Advanced Liver Fibrosis and Reveals Potential Therapeutic Targets. Biomedicines 2022;10:180. [DOI: 10.3390/biomedicines10010180] [Reference Citation Analysis]
2 Lee C, Bak J, Yoon S, Moon JO. Protective Effect of Oligonol on Dimethylnitrosamine-Induced Liver Fibrosis in Rats via the JNK/NF-κB and PI3K/Akt/Nrf2 Signaling Pathways. Antioxidants (Basel) 2021;10:366. [PMID: 33671028 DOI: 10.3390/antiox10030366] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]